Adrafinil
Discover related
3 sources
How the databases line up — = agree, ≈ partial, ≠ differ. In lists, shared items appear in every source and unique ones in only one (matched case-insensitively).
| PsychonautWiki | TripSit | Pharmacology | ||
|---|---|---|---|---|
| Classification | ||||
| Class / category | — | ≈ | ||
| Also known as | AdrafinilOlmifon | — | — | |
| Safety | ||||
| Addiction potential | not addictive with a low potential for abuse | — | — | |
| Dose · Oral | ||||
| Threshold | 100 mg | 100 mg | — | = |
| Light | 150–250 mg | 150–250 mg | — | = |
| Common | 250–400 mg | 250–400 mg | — | = |
| Strong | 400–600 mg | — | — | |
| Heavy | 600 mg+ | 600 mg+ | — | = |
| Duration | ||||
| Onset | 1–2 hours | 45–120 minutes | — | ≠ |
| Total | 6–12 hours | 8–12 hours | — | ≠ |
| After-effects | 2–6 hours | 1–12 hours | — | ≠ |
| Pharmacology | ||||
Dose at a glance
Each database's primary-route ladder on one shared scale — see where ranges line up or shift.
Duration at a glance
Total duration on one shared scale.
TripSit summary
A prodrug to modafinil, this compound is often used to increase wakefulness and alertness. Due to hepatic metabolism it has a slower onset than modafinil and may cause liver damage in excess. Some users have reported acne as an adverse effect. Unregulated in the US.
Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.